Literature DB >> 18182224

Loss of glycinergic and GABAergic inhibition in chronic pain--contributions of inflammation and microglia.

Hanns Ulrich Zeilhofer1.   

Abstract

Tissue trauma, inflammation and neuropathy can under unfortunate condition progress into chronic pain syndromes. It is meanwhile generally accepted that chronic pain, i.e. pain, which persists beyond the resolution of tissue traumata and inflammation, is due to plastic changes in the neuronal processing of sensory stimuli in the CNS. A loss of synaptic inhibition (i.e. dis-inhibition) in the spinal cord dorsal horn has been increasingly recognized as an important process in the development and maintenance of chronic pain of both inflammatory and neuropathic origin. Although inflammation and neuropathy involve distinct mechanisms of synaptic dis-inhibition, the production of inflammatory mediators and/or the activation of immune cells, two events that have once been thought to be normally excluded from the CNS, appear to be critical for both conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18182224     DOI: 10.1016/j.intimp.2007.07.009

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  31 in total

1.  Presynaptic alpha2-GABAA receptors in primary afferent depolarization and spinal pain control.

Authors:  Robert Witschi; Pradeep Punnakkal; Jolly Paul; Jean-Sébastien Walczak; Fernando Cervero; Jean-Marc Fritschy; Rohini Kuner; Ruth Keist; Uwe Rudolph; Hanns Ulrich Zeilhofer
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABAA receptor ligand MP-III-024.

Authors:  Bradford D Fischer; Raymond J Schlitt; Bryan Z Hamade; Sabah Rehman; Margot Ernst; Michael M Poe; Guanguan Li; Revathi Kodali; Leggy A Arnold; James M Cook
Journal:  Brain Res Bull       Date:  2017-03-04       Impact factor: 4.077

3.  Functional Synaptic Integration of Forebrain GABAergic Precursors into the Adult Spinal Cord.

Authors:  Alex Etlin; Joao M Bráz; Julia A Kuhn; Xidao Wang; Katherine A Hamel; Ida J Llewellyn-Smith; Allan I Basbaum
Journal:  J Neurosci       Date:  2016-11-16       Impact factor: 6.167

4.  Better Antiretroviral Central Nervous System Penetration is Not Associated with Reduced Chronic Pain in People Living with Human Immunodeficiency Virus.

Authors:  Nathaniel M Robbins; Kanokporn Chaiklang; Khuanchai Supparatpinyo
Journal:  Antiinfect Agents       Date:  2016

Review 5.  Origins of Phantom Limb Pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 6.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 7.  The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective.

Authors:  Sonia Podvin; Tony Yaksh; Vivian Hook
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

8.  Intrathecal injection of the neurosteroid, DHEAS, produces mechanical allodynia in mice: involvement of spinal sigma-1 and GABA receptors.

Authors:  Seo-Yeon Yoon; Dae-Hyun Roh; Hyoung-Sig Seo; Suk-Yun Kang; Ho-Jae Han; Alvin J Beitz; Jang-Hern Lee
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

9.  Endogenous content and release of [(3)H]-GABA and [(3)H]-glutamate in the spinal cord of chronically undernourished rat.

Authors:  Salvador Quiróz-González; Rodrigo Erick Escartín-Pérez; Francisco Paz-Bermudez; Bertha Segura-Alegría; Celia Reyes-Legorreta; José Carlos Guadarrama-Olmos; Benjamin Florán-Garduño; Ismael Jiménez-Estrada
Journal:  Neurochem Res       Date:  2012-09-15       Impact factor: 3.996

10.  Peripheral and central sensitization in remote spinal cord regions contribute to central neuropathic pain after spinal cord injury.

Authors:  Susan M Carlton; Junhui Du; Huai Yu Tan; Olivera Nesic; Gregory L Hargett; Anne C Bopp; Ammar Yamani; Qing Lin; William D Willis; Claire E Hulsebosch
Journal:  Pain       Date:  2009-10-22       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.